TP53 and colorectal adenocarcinoma: Additionally, CCN2 expression was higher in colorectal adenocarcinoma (COAD) tissues than in normal tissues across various clinicopathological features, including sex, nodal metastasis, and TP53 mutation status (Figure 2C).